Draft Guidance for Industry Comparability Protocols Protein Drug Products...
...In a comparability protocol we recommend that you include a plan for the stability studies that will.....plan to conduct stability studies, we recommend that you state this clearly and provide.....In some cases, no stability studies may be warranted or a commitment to report results..
http://www.fda.gov/OHRMS/DOCKETS/98fr/protcmc.pdf (score=100)

Draft Guidance for Industry Comparability Protocols Protein Drug Products...
...In a comparability protocol we recommend that you include a plan for the stability studies that will.....plan to conduct stability studies, we recommend that you state this clearly and provide.....In some cases, no stability studies may be warranted or a commitment to report results..
http://www.fda.gov/cder/guidance/protcmc.pdf (score=99)

Draft Guidance for Industry: Comparability Protocols — Chemistry,...
...In some cases, no stability studies may be warranted or a commitment to report results from.....A comparability protocol should include a plan for the stability studies that will be performed to.....The plan for evaluating stability could vary depending on the extent of the proposed..
http://www.fda.gov/cber/gdlns/cmprprot.htm (score=56)

ICH Guidance for Industry: Q3B(R) Impurites in New Drug Products
...Stability studies, knowledge of degradation pathways, product development studies, and laboratory.....Any degradation product observed in stability studies conducted at the recommended storage.....and in stability studies, together with a consideration of the degradation profile of..
http://www.fda.gov/cber/gdlns/ichq3br.pdf (score=56)

þÿ
...A comparability protocol should include a plan for the stability studies that will be.....changes that are covered under the protocol and specifies the tests and studies that will.....from stability studies in an AR can be sufficient. If no stability studies are planned, we..
http://www.fda.gov/cber/gdlns/cmprprot.pdf (score=56)

...In some cases, no stability studies may be warranted or a commitment to report results from.....A comparability protocol should include a plan for the stability studies that will be performed to.....The plan for evaluating stability could vary depending on the extent of the proposed..
http://www.fda.gov/cder/guidance/5427dft.doc (score=56)

Draft Guidance for Industry: Comparability Protocols -Protein Drug Products...
...In a comparability protocol we recommend that you include a plan for the stability studies that will.....In some cases, no stability studies may be warranted or a commitment to report results, when.....If you don’t plan to conduct stability studies, we recommend that you state this clearly and provide..
http://www.fda.gov/cber/gdlns/protcmc.htm (score=56)

...In a comparability protocol we recommend that you include a plan for the stability studies that will.....In some cases, no stability studies may be warranted or a commitment to report results, when.....If you don't plan to conduct stability studies, we recommend that you state this clearly and provide..
http://www.fda.gov/cder/guidance/protcmc.doc (score=56)

MDI and DPI Drug Products
...manufacturing, processing, packaging, controls, stability testing, or labeling operations.....For MDI and DPI drug products, certain studies should be performed to determine.....stability test storage conditions. Additional studies should be performed to characterize..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=20)

stability guidance -draft
...stability studies in accordance with the approved stability protocol on the first production batch.....long-term and accelerated stability studies and annual batches thereafter on long-term studies using.....and accelerated stability studies and annual batches thereafter on long-term studies using the..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=20)

PTC in Manufacture and Testing of Monoclonal Antibody Products for Human Use
...Results should be correlated closely with studies of conjugate stability.Studies of the immunoconjugate should be.....the immunoconjugate and the stability of the conjugate itself, separate studies of the.....Initial studies of therapeutic mAb in phase 1 are generally escalation studies of single..
http://www.fda.gov/cber/gdlns/ptc_mab.pdf (score=19)

IND content and format for Phase 1 studies
...1 Studies of Drugs, Including Well-Characterized, Therapeutic,Biotechnology-derived.....Information to support the stability of the drug..substance during the toxicologic studies.....Information to support the stability of the drug..substance during the toxicologic studies..
http://www.fda.gov/cder/guidance/phase1.pdf (score=19)

Content and Format of INDs for Phase 1 Studies of Drugs, Inclu
...Information to support the stability of the drug..substance during the toxicologic studies.....Information to support the stability of the drug..substance during the toxicologic studies.....toxicologic reports of completed animal studies as initial support for human..studies, and..
http://www.fda.gov/cder/guidance/clin2.pdf (score=19)

...Depending upon the nature of the components of the immunoconjugate and the stability of the conjugate itself, separate studies of the.....Stability of product Product stability should meet the demands imposed by the clinical.....Initial studies of therapeutic mAb in phase 1 are generally escalation studies of single..
http://www.fda.gov/cber/gdlns/ptc_mab.txt (score=19)

6003dft.doc
...therefore, real-time concurrent stability studies on the product potentially affected by.....knowledge from process development studies, small scale evaluation/validation studies, 331.....evaluated for its impact on stability, since proteins are frequently sensitive to changes..
http://www.fda.gov/cder/guidance/6003dft.pdf (score=19)

Draft Guidance: ICH Q5E: Comparability of Biotechnological/Biological...
...Furthermore, stability studies might be able to detect subtle differences that are not readily.....Generally, therefore, real-time concurrent stability studies on the product potentially affected by.....Accelerated and stress stability studies are often useful tools to establish degradation profiles..
http://www.fda.gov/cber/gdlns/ichcompbio.htm (score=19)

International Conference on Harmonisation; Draft Guidance on Q5E...
...therefore, real-time concurrent stability studies on the product potentially affected by.....knowledge from process development studies, small scale evaluation/validation studies, 331.....evaluated for its impact on stability, since proteins are frequently sensitive to changes..
http://www.fda.gov/cber/gdlns/ichcompbio.pdf (score=19)

Guidance for Industry
...available long-term stability data,14 plus short-term stress studies under high.....For additional details about food-effect bioavailability studies and fed bioequivalence.....The new information needed to support blister packaging would typically be limited to..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04D-0228-GDL0001-6283dft.pdf (score=18)

Guidance for Industry: Fixed Dose Combination and Co-Packaged Drug Products...
...Data would typically include limited accelerated and available long-term stability data,14 plus short-term stress studies under.....Data would typically include accelerated and available long-term stability data,18 plus short-term stress studies under high.....For additional details about food-effect bioavailability studies and fed bioequivalence studies, see the guidance for..
http://www.fda.gov/oc/initiatives/hiv/hivguidance.html (score=18)

FDA/ORA Compliance Program Guidance: GLP Guidance for Industry Q and A
...overdosage studies in the target species, animal safety studies in the target species, tissue residue accumulation and depletion.....What expiration date is placed on the label of test articles whose stability is being.....Nonetheless, the agency realizes that not all of the GLP provisions apply to all studies and, indeed, for some special studies..
http://www.fda.gov/ora/compliance_ref/bimo/GLP/qna.htm (score=18)

Las Vegas Injury Lawyer